Michael Graves - Interim Executive Chair & PEO, Director at EAGLE PHARMACEUTICALS, INC.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Michael Graves since 20 Aug 2025

Reported holdings for Michael Graves in EAGLE PHARMACEUTICALS, INC.

Form 4 holding Interim Executive Chair & PEO, Director

EAGLE PHARMACEUTICALS, INC.

Security class
Common Stock
Shares / value
10,360
Estimated value
$53,147
Report date
27 Oct 2023
Price
$5.13
Ownership
Direct
Form 4 holding Interim Executive Chair & PEO, Director

EAGLE PHARMACEUTICALS, INC.

Security class
Employee Stock Option (right to buy)
Shares / value
293,000
Estimated value
Report date
21 Dec 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Michael Graves in EAGLE PHARMACEUTICALS, INC.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .